REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,026 | +320.5% | 10,069 | +273.9% | 0.01% | +233.3% |
| Q1 2023 | $244 | -78.1% | 2,693 | -90.8% | 0.00% | -81.2% |
| Q4 2022 | $1,112 | -99.9% | 29,282 | -27.4% | 0.02% | +45.5% |
| Q3 2022 | $1,013,000 | +105.1% | 40,317 | +712.7% | 0.01% | +120.0% |
| Q1 2021 | $494,000 | -60.3% | 4,961 | -61.1% | 0.01% | -86.1% |
| Q3 2020 | $1,243,000 | +12.3% | 12,767 | +79.8% | 0.04% | +9.1% |
| Q2 2020 | $1,107,000 | +329.1% | 7,099 | +296.4% | 0.03% | +94.1% |
| Q1 2020 | $258,000 | – | 1,791 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |